Joincare Pharmaceutical Group IndustryLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Does Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Have A Healthy Balance Sheet?
Mar 14
Earnings Working Against Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Share Price
Jan 03Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?
Nov 17Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market
Aug 13We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease
Jun 23Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being
May 31Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings
Apr 09Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel
Mar 04CEO
Joincare Pharmaceutical Group IndustryLtd has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| VP & Director | less than a year | CN¥2.02m | no data | |
| VP, CFO & Director | no data | CN¥2.26m | 0.039% CN¥ 7.7m | |
| VP & Director | no data | CN¥2.26m | 0.071% CN¥ 13.9m | |
| Financial Controller | no data | CN¥921.50k | no data | |
| Board Secretary | less than a year | no data | no data | |
| Vice President | 1.7yrs | CN¥2.02m | no data | |
| Vice President | less than a year | no data | no data | |
| Vice President | less than a year | no data | no data |
0.7yrs
Average Tenure
40yo
Average Age
Experienced Management: 600380's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| VP & Director | less than a year | CN¥2.02m | no data | |
| VP, CFO & Director | no data | CN¥2.26m | 0.039% CN¥ 7.7m | |
| VP & Director | no data | CN¥2.26m | 0.071% CN¥ 13.9m | |
| Chairman of the Board of Directors | no data | CN¥3.34m | no data | |
| Vice Chairman of the Board of Directors | no data | CN¥4.37m | no data | |
| Member of the Supervisory Board | no data | no data | 0.0021% CN¥ 408.7k | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Independent Director | 1.7yrs | CN¥35.00k | no data | |
| Independent Director | no data | CN¥120.00k | no data | |
| Independent Director | no data | CN¥120.00k | no data | |
| Independent Director | no data | CN¥120.00k | no data | |
| Supervisor | less than a year | no data | no data |
0.8yrs
Average Tenure
54yo
Average Age
Experienced Board: 600380's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 06:44 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Joincare Pharmaceutical Group Industry Co.,Ltd. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Ling Bo Tu | China Minzu Securities |
| Shitong Han | Citic Securities Co., Ltd. |